Dr Reddys lab reports 25% rise in its Q1 net profit

20 Jul 2011 Evaluate

Dr Reddys Laboratories has reported results for its first quarter ended June 30, 2011.

The company’s net profit for the quarter has surged by 25.38% at Rs 262.74 crore as compared to Rs 209.55 crore for the quarter ended June 30, 2010. Its net income from sales and services has increased by 17.54% to Rs 1978.32 crore for the quarter under review from Rs 1683.13 crore for the corresponding quarter of the previous year.

Dr Reddys, a global pharmaceutical company, has a global presence in more than 100 countries, with subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries and third-party distribution set ups in 21 countries.

Dr. Reddys Lab Share Price

1342.45 16.45 (1.24%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.